Display options
Cite
Rani GF, Ashwin H, Brown N, et al. Hematological consequences of malaria in mice previously treated for visceral leishmaniasis. Wellcome Open Res. 2021;6:83doi: 10.12688/wellcomeopenres.16629.2.
Rani, G. F., Ashwin, H., Brown, N., Hitchcock, I. S., & Kaye, P. M. (2021). Hematological consequences of malaria in mice previously treated for visceral leishmaniasis. Wellcome open research, 683. https://doi.org/10.12688/wellcomeopenres.16629.2
Rani, Gulab Fatima, et al. "Hematological consequences of malaria in mice previously treated for visceral leishmaniasis." Wellcome open research vol. 6 (2021): 83. doi: https://doi.org/10.12688/wellcomeopenres.16629.2
Rani GF, Ashwin H, Brown N, Hitchcock IS, Kaye PM. Hematological consequences of malaria in mice previously treated for visceral leishmaniasis. Wellcome Open Res. 2021 Jun 18;6:83. doi: 10.12688/wellcomeopenres.16629.2. eCollection 2021. PMID: 34286101; PMCID: PMC8276186.
Copy Download .nbib Format: NLM
Share it on

Wellcome Open Res. 2021 Jun 18;6:83. doi: 10.12688/wellcomeopenres.16629.2. eCollection 2021.

Hematological consequences of malaria in mice previously treated for visceral leishmaniasis.

Wellcome open research

Gulab Fatima Rani, Helen Ashwin, Najmeeyah Brown, Ian S Hitchcock, Paul M Kaye

Affiliations

  1. Hull York Medical School, University of York, UK, York, N. Yorks, Yo10 5DD, UK.
  2. Department of Biology, University of York, UK, York, N. Yorks, Yo10 5DD, UK.

PMID: 34286101 PMCID: PMC8276186 DOI: 10.12688/wellcomeopenres.16629.2

[No abstract available.]

Copyright: © 2021 Rani GF et al.

Keywords: chemotherapy; coinfection; hematology; malaria; mouse models; visceral leishmaniasis

Conflict of interest statement

No competing interests were disclosed.

References

  1. J Infect. 2011 Sep;63(3):200-6 - PubMed
  2. J Leukoc Biol. 1989 Feb;45(2):97-104 - PubMed
  3. Blood. 2000 Mar 1;95(5):1642-51 - PubMed
  4. PLoS Negl Trop Dis. 2012;6(4):e1617 - PubMed
  5. PLoS One. 2015 Mar 25;10(3):e0121057 - PubMed
  6. Nature. 2013 Jun 13;498(7453):228-31 - PubMed
  7. PLoS Pathog. 2017 Jul 3;13(7):e1006465 - PubMed
  8. BMC Infect Dis. 2019 Mar 8;19(1):239 - PubMed
  9. J Immunol. 2020 Jun 1;204(11):2949-2960 - PubMed
  10. Infect Immun. 1976 Aug;14(2):457-62 - PubMed
  11. Science. 2016 Apr 22;352(6284):aaf1098 - PubMed
  12. Front Immunol. 2018 Dec 18;9:2958 - PubMed
  13. Am J Pathol. 2009 Sep;175(3):1107-15 - PubMed
  14. PLoS Pathog. 2019 Nov 8;15(11):e1008145 - PubMed
  15. Int J Parasitol. 2010 Aug 15;40(10):1171-6 - PubMed
  16. J Immunol. 2006 Aug 15;177(4):2518-26 - PubMed
  17. Wellcome Open Res. 2019 Dec 10;4:198 - PubMed
  18. Immunol Res. 2021 Feb;69(1):1-7 - PubMed
  19. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):48-54 - PubMed
  20. Immunol Today. 2000 Feb;21(2):73-8 - PubMed
  21. Malar Res Treat. 2017;2017:6816913 - PubMed
  22. Am J Pathol. 2006 Sep;169(3):943-53 - PubMed
  23. Am J Trop Med Hyg. 2005 Jun;72(6):702-7 - PubMed
  24. PLoS Pathog. 2017 Aug 7;13(8):e1006422 - PubMed
  25. BMC Infect Dis. 2019 Oct 15;19(1):849 - PubMed
  26. Blood Adv. 2021 Mar 23;5(6):1627-1637 - PubMed
  27. Clin Infect Dis. 2017 Oct 30;65(10):1703-1710 - PubMed
  28. Acta Trop. 2004 Jul;91(2):161-6 - PubMed
  29. BMC Public Health. 2013 Apr 11;13:332 - PubMed
  30. Trends Parasitol. 2005 Feb;21(2):75-80 - PubMed
  31. J Trop Med. 2015;2015:796182 - PubMed
  32. HIV AIDS (Auckl). 2018 Oct 15;10:193-201 - PubMed
  33. Immunity. 2021 Jan 12;54(1):32-43 - PubMed
  34. Trop Med Int Health. 2011 Feb;16(2):186-92 - PubMed
  35. PLoS Negl Trop Dis. 2014 Jan 02;8(1):e2536 - PubMed
  36. J Infect Dis. 2005 Feb 1;191(3):410-21 - PubMed
  37. Int J Infect Dis. 2020 Jun;95:44-49 - PubMed
  38. PLoS Negl Trop Dis. 2010 Jun 08;4(6):e705 - PubMed
  39. Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7545-7550 - PubMed
  40. Infect Immun. 2000 Apr;68(4):1840-8 - PubMed
  41. Infect Immun. 2005 Jun;73(6):3531-9 - PubMed
  42. Malar J. 2012 Dec 06;11:407 - PubMed
  43. PLoS Negl Trop Dis. 2015 Apr 02;9(4):e0003699 - PubMed

Publication Types

Grant support